The Analytical LCM Product Lead is the single point of accountability for global analytical lifecycle management (LCM) of Takeda’s live-attenuated tetravalent dengue vaccine, manufactured in Vero cells and presented as a lyophilized drug product with diluent for reconstitution. The role owns the vaccine’s analytical LCM strategy across its commercial lifecycle and maintains the analytical roadmap and method risk register in alignment with the broader CMC program plan. The position integrates and oversees vaccine-specific analytical LCM activities, including analytical methods and control strategies, regulatory filings and specification justifications, technology transfer, method remediation, process changes, reference standards and key materials, virus seeds and cell banks, analytical change control, and comparability. It coordinates stakeholders across MSAT, Pharm Sci, Quality, Regulatory, GSQ, QC sites, IT, and internal and external laboratories to align priorities, resourcing, ways of working, and network strategy. The role ensures appropriate quality management, training, documentation, data integrity, and inspection readiness across the network. It also advances analytical technology innovation and digital-forward platforms, embedding risk-based thinking in method development, qualification, validation, and lifecycle management to improve robustness, reduce investigations, and accelerate technology transfer and comparability.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior